Home › IGA Glomerulonephritis › New York › New York City
IGA Glomerulonephritis clinical trials in New York City, NY
4 studies for IGA Glomerulonephritis are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
RecruitingPhase 3
- Col Uni Med Center New York Presby, New York
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
RecruitingPhase 3
- Icahn School of Medicine at Mount Sinai, New York
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecruitingPhase 3
- Icahn School of Medicine at Mount Sinai, New York
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
RecruitingObservational study
- The Rogosin Institute, New York
IGA Glomerulonephritis trials in other cities
- Houston, TX9 studies
- Denver, CO5 studies
- Orlando, FL5 studies
- Sioux City, IA4 studies
- Los Angeles, CA4 studies
- Boston, MA3 studies
- Philadelphia, PA3 studies
- Cedar Rapids, IA3 studies
- Johns Creek, GA3 studies
- Columbus, OH3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.